LBF20207PG49
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1798 |
LipidMaps | LMFA03010010 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG49 |
Prostaglandin H2 | |
---|---|
Structural Information | |
(9α,11α) -Epidioxy-15S-hydroxy-prosta- (cis-5,trans-13) -dien-1-oic acid | |
| |
Formula | C20H32O5 |
Exact Mass | 352.224974134 |
Average Mass | 352.46508 |
SMILES | C(CC[C@H](O)C=C[C@@H]([C@H]21)[C@@H](CC=CCCCC(O)=O)[C@@H](OO2)C1)CC |
Physicochemical Information | |
PGH2 was firstly reported as a potent vasoconstrictor. Hamberg_M et al. And PGH2 has been reported as a TP receptor agonist which irreversibly aggregates human platelets at 50-100 ng/ml and also as a suicide substrate for platelet TX synthase proscessing a Ki value of 18 mu M . Jones_DA et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|